The Onco Life Podcast

Lung cancer is often linked to smoking, but tobacco is not the only risk factor. This episode explores the leading causes and risk factors of lung cancer, including radon, secondhand smoke, genetics, air pollution, and workplace exposure.

• Why smoking is the leading cause of lung cancer
• How secondhand smoke affects non-smokers
• Why radon exposure can increase lung cancer risk
• How family history and genetics may affect your risk
• Which workplace hazards can damage your lungs
• How air pollution and lung disease raise cancer risk
• When lung cancer screening may be recommended

Learn how understanding your personal risk factors can support prevention, early detection, and better conversations with a lung cancer specialist.

Blog Link: Causes and Risk Factors of Lung Cancer

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we break down the latest FDA cancer treatment approvals from Q2 2026 and explain what they could mean for patients navigating cancer care.

You’ll learn:

• Which new FDA-approved cancer treatments were introduced for breast, blood, bladder, prostate, kidney, and rare cancers
• Why are many new therapies designed for patients with specific genetic markers or biomarkers
• The most important questions to ask your oncologist about newly approved treatments
• The difference between full FDA approval and fast-track approval, and why it matters
• How clinical trial results help determine whether a treatment is right for you
• Why biomarker and genetic testing play a key role in personalized cancer treatment
• How staying informed and asking the right questions can help you make confident treatment decisions

As cancer care becomes more personalized, understanding new FDA approvals can help you have more informed conversations with your healthcare team. This episode explains what these approvals mean, who they may benefit, and how to determine whether a newly approved treatment could be an option for your specific diagnosis.

Blog Link: New FDA Cancer Treatment Approvals: Questions Patients Should Ask

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

A new clinical trial is bringing hope to patients with advanced head and neck cancer who have limited treatment options after standard therapies stop working. In this episode, we break down the latest research on a new targeted antibody injection and what these early findings could mean for patients and their families.

You’ll learn:

• What the new head and neck cancer trial discovered
• How the investigational bispecific antibody treatment works
• Why is this targeted injection different from a cancer vaccine
• What complete tumor responses and tumor shrinkage really mean
• Why HPV status plays an important role in treatment outcomes
• What Phase II trial results can and cannot prove
• Which patients may benefit most from this promising new therapy
• Important questions patients should ask their oncology team about clinical trials and treatment options

While the results are encouraging, this treatment is still experimental, and larger Phase 3 studies are needed before it becomes a standard option. Tune in to understand what these breakthrough findings mean and why cautious optimism is the right approach.

Blog Link: Advanced Head and Neck Cancer Treatment: New Trial Shows Promising Results

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we discuss a major milestone in Malaysian healthcare as Onco Life Centre becomes the first non-hospital-based oncology provider in Malaysia to earn ACHSI accreditation. This internationally recognized achievement highlights the centre’s commitment to patient safety, clinical excellence, and world-class cancer care.

You’ll learn:

• What ACHSI accreditation is and why it is recognized around the world
• Why Onco Life Centre’s achievement is a first for independent oncology care in Malaysia
• How ACHSI evaluates healthcare providers on safety, quality, and clinical outcomes
• What accreditation means for patients receiving chemotherapy, targeted therapy, and immunotherapy
• How international standards help ensure consistent, evidence-based cancer treatment
• Why patient-centered care is a key part of the accreditation process
• How continuous monitoring and quality improvement help maintain high standards of care
• What this milestone means for cancer patients seeking trusted treatment options in Malaysia

Choosing the right cancer care provider is one of the most important decisions a patient can make. This episode explains how ACHSI accreditation reflects Onco Life Centre’s dedication to delivering safe, effective, and internationally benchmarked cancer care while continuously improving the patient experience at every stage of the treatment journey.

Blog Link: Elevating Cancer Care: Onco Life Centre Achieves Prestigious ACHSI Accreditation

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we explore groundbreaking new research showing how artificial intelligence may help detect breast cancer years before a traditional diagnosis. A large Swedish study found that AI systems could identify subtle signs of breast cancer on mammograms up to six years before doctors confirmed the disease.

You’ll learn:

• How AI detected breast cancer signs years before diagnosis
• What researchers discovered after analyzing nearly 89,000 mammograms
• Why AI scores increased as patients got closer to a breast cancer diagnosis
• How early detection could lead to more personalized breast cancer screening
• The difference between promising research results and proven clinical outcomes
• Why AI is designed to support doctors, not replace them
• What this breakthrough could mean for women’s health and breast cancer screening in Malaysia

This episode breaks down the study’s findings in simple terms and explains how AI-powered breast cancer detection could change the future of screening, risk assessment, and early diagnosis. While more research is needed before widespread adoption, the results highlight the growing role of artificial intelligence in helping doctors identify cancer earlier and improve patient care.

Blog Link: AI Can Detect Breast Cancer Up to 6 Years Before Diagnosis

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we explain how genetic testing can help identify inherited breast cancer risk and why it may be an important step for individuals and families with a history of cancer.

You’ll learn:

• What genetic testing is and how it helps assess breast cancer risk
• The role of BRCA1 and BRCA2 gene mutations in inherited cancer risk
• Who should consider genetic testing, including those with a strong family history of cancer
• Why breast cancer diagnosed before age 50 may be linked to inherited gene changes
• How ovarian cancer, pancreatic cancer, prostate cancer, and male breast cancer can signal a hereditary cancer risk
• Why people with Ashkenazi Jewish heritage may benefit from genetic screening
• What happens during the testing process and how genetic test results are interpreted
• How genetic testing can guide earlier screening, prevention planning, and family health decisions
• Common myths about BRCA testing and inherited cancer risk

Whether you're concerned about your family history or want to better understand your personal cancer risk, this episode provides a clear guide to genetic testing for breast cancer and how it can support informed healthcare decisions.

Blog Link: Genetic Testing for Breast Cancer: Who Should Get Tested?

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we explore practical ways to reduce lung cancer risk and improve long-term lung health through healthy lifestyle choices, early detection, and awareness of common risk factors.

You’ll learn:

• What increases the risk of lung cancer, including smoking, secondhand smoke, and environmental exposures
• Why smoking is the leading cause of lung cancer and how quitting can lower your risk over time
• How radon gas, asbestos, workplace chemicals, and air pollution may affect lung health
• Simple lifestyle changes that can help support healthy lungs and overall wellness
• The benefits of regular exercise, healthy eating, and adequate sleep
• Why workplace safety and protective equipment matter for cancer prevention
• How lung cancer screening and early detection can help high-risk individuals
• What steps can you take today to help protect your lungs in the future

Whether you're looking to quit smoking, understand your personal risk factors, or learn more about lung cancer prevention, this episode provides a clear and practical guide to making healthier choices for better lung health.

Blog Link: Preventing Lung Cancer and Reducing Risk

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we explore how targeted therapy drugs are changing the way liver cancer is treated, offering more precise treatment options for patients with advanced disease.

You’ll learn:

• What targeted therapy is and how it works against liver cancer cells
• How targeted drugs help slow tumor growth and block cancer growth signals
• The difference between tyrosine kinase inhibitors and monoclonal antibodies
• When targeted therapy may be recommended for hepatocellular carcinoma (HCC) and primary liver cancer
• How these treatments can help when surgery or a liver transplant is not possible
• Common side effects, including fatigue, skin changes, and high blood pressure
• The role of clinical trials in developing new targeted therapies
• How targeted therapy may be combined with other liver cancer treatments for better outcomes

Whether you are a patient, caregiver, or simply looking to understand modern liver cancer treatment options, this episode provides a clear overview of how targeted therapies help control disease progression and improve quality of life.

Blog Link: Targeted Therapy Drugs for Liver Cancer: A Complete Guide

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we explain the connection between colon polyps and colorectal cancer risk, helping you understand how early detection and screening can prevent serious health problems.

You’ll learn:

• What colon polyps are and why they develop in the lining of the colon
• The different types of polyps, including adenomatous polyps and sessile serrated polyps
• Which risk factors may increase the chance of developing colon polyps and colorectal cancer
• How colon cancer screening and colorectal cancer screening help detect polyps early
• When polyps may become cancerous and why removal is important
• Healthy lifestyle habits that may help reduce the risk of colon cancer
• Why family history and inflammatory bowel disease can affect your colorectal cancer risk
• How early detection can improve long-term health outcomes

Whether you're concerned about your personal risk factors or want to learn more about colon health, this episode provides a simple guide to understanding colon polyps, colorectal cancer risk, and the importance of regular screening.

Blog Link: Colon Polyps and Colorectal Cancer Risk

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.

In this episode, we break down the Gleason score and explain why it plays such an important role in prostate cancer diagnosis and treatment planning.

You’ll learn:

• What the Gleason score is and how it measures prostate cancer severity
• How prostate biopsy results help determine cancer grade and risk level
• The difference between low-grade, intermediate-grade, and high-grade prostate cancer
• Why PSA levels and biopsy findings work together in diagnosis
• When active surveillance may be appropriate for low-risk prostate cancer
• How specialists use Gleason scores to guide treatment decisions
• Why early detection and regular prostate health screenings matter

Whether you have recently received a prostate cancer diagnosis or want to better understand prostate health, this episode provides a simple guide to how prostate cancer is graded and what those results mean for your care.

Blog Link: Understanding the Gleason Score in Prostate Cancer Diagnosis

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.